Catalyst Wire Dossier Catalyst Wire Dossier

Unspecified cholesterol-lowering drug

· Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified cholesterol-lowering drug, covering 2024-08-15 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150) [Phase 4]

See pricing